Tag: whole genome and exome sequencing market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Whole Genome And Exome Sequencing Market Size Changed, over the years?

The market size of whole genome and exome sequencing has seen a significant increase in the past few years. It is projected to expand from a worth of $2.02 billion in 2024 to about $2.53 billion in 2025, experiencing a compound annual growth rate (CAGR) of 24.8%. This considerable growth during the historic period is linked to factors such as lessening sequencing expenses, an uptick in genetic disorders, clinical uses, genomic data repositories, and progress in bioinformatics.

How Much Will the Whole Genome And Exome Sequencing Market Be Worth in 2029?

Expectations are that the market size of whole genome and exome sequencing will experience significant expansion in the coming years, reaching $6.14 billion in 2029 with a CAGR of 24.9%. The prediction for growth during this period is largely due to factors such as population genomics initiatives, an increasing requirement for precision medicine, advancements in individual cell sequencing, the broadening scope of non-invasive prenatal tests (NIPT), and their application in studying rare diseases. Key trends anticipated during this forecast period encompass wider clinical adoption, swift progress in sequencing technologies, the emergence of populous scale genomic studies, the amalgamation of artificial intelligence and machine learning, and increasing applications within the field of oncology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which is the Largest Company in the Whole Genome And Exome Sequencing Market?

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

What Are the Main Market Drivers in the Whole Genome And Exome Sequencing Industry?

The increasing need for customized healthcare is projected to fuel the expansion of the whole genome and exome sequencing market. This sort of healthcare tailors to every patient’s unique needs considering their genetic, environmental, and lifestyle aspects. Whole genome and exome sequencing delivers a detailed analysis of one’s genetic constitution, thereby permitting custom-made healthcare plans based on individual genetics, environment, and lifestyle. As an example, the Personalized Medicine Coalition (PMC), a US organization that advocates for the understanding and incorporation of personalized medicine, stated in October 2022 that over 75,000 genetic testing products and 300 customized medicines are estimated to be available in 2022. Additionally, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave approval to 37 fresh molecular entities (NMEs) in 2022. Moreover, around 34% or 12 of the 35 therapeutic NMEs have been categorized as personalized. This escalating need for personalized treatments stimulates the growth of the market for whole genome and exome sequencing.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

How Is the Whole Genome And Exome Sequencing Market Segments Structured?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

What Strategic Trends Are Transforming the Whole Genome And Exome Sequencing Market?

Leading firms in the whole genome and exome sequencing market are concentrating on creating sophisticated technological innovations such as ultra-fast NGS (next-generation sequencing) analysis, in order to remain competitive. The ultra-fast NGS analysis is a breakthrough technology that allows for rapid processing of next-generation sequencing (NGS) data, drastically cutting the time it takes to analyze genomic data. In January 2023, for example, QIAGEN Digital Insights (QDI), a bioinformatics company based in the United States, unveiled their ultra-fast NGS analysis platform. This platform offers the ability to process an entire genome in 25 minutes at a cloud computing cost of $1, demonstrating its efficiency, affordability, and scalability. This significant technological advancement greatly improves the speed and accessibility of genomic data analysis, considerably impacting the whole genome and exome sequencing market by accelerating decision-making processes and increasing the acceptance of personalized medicine.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which Global Regions Offer the Highest Growth in the Whole Genome And Exome Sequencing Market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

This Report Delivers Insight On:

1. How big is the whole genome and exome sequencing market, and how is it changing globally?

2. Who are the major companies in the whole genome and exome sequencing market, and how are they performing?

3. What are the key opportunities and risks in the whole genome and exome sequencing market right now?

4. Which products or customer segments are growing the most in the whole genome and exome sequencing market?

5. What factors are helping or slowing down the growth of the whole genome and exome sequencing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the whole genome and exome sequencing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Whole Genome And Exome Sequencing Market From 2025 To 2029?

The market size for whole genome and exome sequencing has seen a significant expansion in the past years. It is projected to rise from a value of $2.02 billion in 2024 to a worth of $2.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.8%. The impressive escalation during the historical period can be tied to factors such as the reduction in sequencing costs, the increase in genetic disorders, clinical usages, the growth of genomic data repositories, and advancements made in the field of bioinformatics.

The market size for whole genome and exome sequencing is anticipated to experience a massive increase in the upcoming years, reaching a size of $6.14 billion in 2029 with a compound annual growth rate (CAGR) of 24.9%. Factors predicted to contribute to this surge in the forecasted period are initiatives in population genomics, the growing need for precision medicine, advances in single-cell sequencing, the widening of non-invasive prenatal testing (NIPT), and its use in researching rare diseases. The key trends likely to be seen during this period are an increased clinical uptake, swift progress in the sequencing technologies, a rise in population-scale genomic studies, the incorporation of artificial intelligence (AI) and machine learning (ML), with a wider application in oncology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

What Are the Core Market Drivers Propelling Growth in the Whole Genome And Exome Sequencing Industry?

The increasing preference for personalized healthcare is set to bolster the expansion of the whole genome and exome sequencing industry in the forthcoming years. Customized medicine uses an approach that customizes healthcare choices and interventions to cater to personal attributes of each patient, including factors such as genetic make-up, environment, and lifestyle habits. Whole genome and exome sequencing comes into play in this field by giving an in-depth analysis of a patient’s genetic structure. This enables tailor-made medical decisions and interventions based on their distinctive genetic, environmental, and lifestyle factors. For example, in October 2022, the Personalized Medicine Coalition (PMC), an organization based in the U.S. that advocates the comprehension and uptake of customized medicine, projected that over 75,000 genetic test products and 300 tailored medicines would hit the market in 2022. Moreover, the Center for Drug Evaluation and Research (CDER) under the Food and Drug Administration sanctioned 37 new molecular entities (NMEs) in 2022. Additionally, approximately 34% of the 35 therapeutic NMEs, equating to 12 of them, have been categorized as personalized. As such, the surging popularity of customized medicine is fueling the expansion of the whole genome and exome sequencing industry.

How Is the Whole Genome And Exome Sequencing Market Segmented?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

Which Regions Are Driving the Next Phase of the Whole Genome And Exome Sequencing Market Growth?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Whole Genome And Exome Sequencing Industry?

Leading enterprises involved in the whole genome and exome sequencing markets are intensifying their efforts on developing superior technology-based solutions, like ultra-fast NGS (next-generation sequencing) analysis, to establish a competitive advantage. The ultra-fast NGS analysis, a state-of-the-art innovation, allows the processing of NGS data at an incredibly fast rate, thereby minimizing the time needed for genomic data analysis. For example, QIAGEN Digital Insights (QDI), a bioinformatics firm based in the US, introduced the ultra-fast NGS analysis platform in January 2023. The platform, costing $1 for processing an entire genome in 25 minutes via cloud computing, promotes not only efficiency and affordability, but also scalability. This technological advancement considerably boosts the speed and accessibility of genomic data analysis, making it crucial in the whole genome and exome sequencing market for facilitating swift decision-making and broader acceptance of personalized medicine.

View the full report here:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

How Is the Whole Genome And Exome Sequencing Market Defined and What Are Its Core Parameters?

Whole genome sequencing (WGS) and exome sequencing (ES) are comprehensive genetic analysis techniques that involve determining the complete DNA sequence of an organism’s genome and sequencing the protein-coding regions of the genome. These analyses are used to sequence a person’s DNA for diagnosing genetic diseases and identifying cancer mutations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the whole genome and exome sequencing market grown in recent years?

The whole genome and exome sequencing market has expanded rapidly, expected to grow from $2.02 billion in 2024 to $2.53 billion in 2025, at a CAGR of 24.8%. The market’s historic growth can be attributed to decreasing sequencing costs, rising cases of genetic disorders, increased clinical applications, expanding genomic data repositories, and advancements in bioinformatics.

How is the whole genome and exome sequencing market size expected to evolve during the forecast period?

The whole genome and exome sequencing market is expected to witness exponential growth, reaching $6.14 billion by 2029 at a CAGR of 24.9%. Growth is attributed to population genomics initiatives, increasing demand for precision medicine, advances in single-cell sequencing, expanding non-invasive prenatal testing (NIPT), and rare disease research applications. Major trends include expanded clinical adoption, rapid sequencing advancements, population-scale genomic studies, AI and ML integration, and growing applications in oncology.

Get your whole genome and exome sequencing market report here!

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which key drivers are propelling the whole genome and exome sequencing market’s growth?

The burgeoning interest in customized medical treatment is predicted to fuel the expansion of the whole genome and exome sequencing market going forward. Customized medicine refers to the medical care practice that customizes healthcare decisions and actions to the particularities of every patient, taking into account aspects like genetics, environment, and way of life. Whole genome and exome sequencing aids in customized medicine by providing an all-encompassing examination of a person’s genetic structure. This allows health care decisions and actions to be customized based on their distinct genetic, environmental, and lifestyle factors. For instance, the Personalized Medicine Coalition (PMC), a US-based entity that encourages the comprehension and adoption of personalized medicine, projected in October 2022 that in excess of 75,000 genetic testing products and 300 personalized medicines will grace the market in 2022. Moreover, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave the green light to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, nearly 34%, amounting to 12, fall under the personalized category. As a consequence, the growing demand for personalized medicine is acting as a catalyst for the growth of the whole genome and exome sequencing market.

What are the market segments in the whole genome and exome sequencing industry?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which leading companies are shaping the growth of the whole genome and exome sequencing market?

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

What key trends are currently impacting the whole genome and exome sequencing market’s development?

Leading companies in the whole genome and exome sequencing markets are shifting their efforts to create cutting-edge technological systems, like ultra-fast NGS (next-generation sequencing) analysis, to stand out in the market. This new technology allows the processing of next-generation sequencing (NGS) data at an unprecedented pace, drastically cutting down on the time needed for genomic data analysis. To demonstrate, in January 2023, QIAGEN Digital Insights (QDI), a bioinformatics firm in the US, unveiled their ultra-fast NGS analysis platform. This platform boasts capabilities such as completing a whole genome process in 25 minutes at a cloud computing cost of $1, thus encouraging efficiency, cost-effectiveness, and scalability. This technological breakthrough significantly improves the speed and availability of genomic data analysis, making it particularly valuable in the whole genome and exome sequencing market by facilitating prompt decision-making and broader implementation of personalized medicine.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

Which geographic areas are influencing the growth of the whole genome and exome sequencing market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Prenatal DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Rapidly is the Whole Genome And Exome Sequencing Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

The size of the total genome and exome sequencing market has seen rapid expansion in recent years. The market, which stood at a value of $2.02 billion in 2024, is projected to climb to a size of $2.53 billion in 2025 with a Compound Annual Growth Rate (CAGR) of around 24.8%. The impressive growth recorded in the historical period can be traced back to factors such as the reduction in sequencing costs, an increase in genetic disorders, clinical use cases, genomic data archives, and advancements in the field of bioinformatics.

It is projected that the market size for whole genome and exome sequencing will experience substantial expansion in the forthcoming years, reaching $6.14 billion in 2029, growing at a compound annual growth rate (CAGR) of 24.9%. This growth over the forecast span can be linked to factors like initiatives in population genomics, an increasing need for precision medicine, progress in single-cell sequencing, growth in the scope of non-invasive prenatal testing (NIPT), and its application in the research of rare diseases. Key trends predicted during the forecasted timeline include wider clinical adoption, accelerated progress in sequencing technologies, emergence of large-scale genomic studies, the incorporation of artificial intelligence (AI) and machine learning (ML), along with widened applications in the field of oncology.

Which Drivers Are Expected to Have the Greatest Impact on the Whole Genome And Exome Sequencing Market’s Growth?

The burgeoning interest in customized medical treatment is predicted to fuel the expansion of the whole genome and exome sequencing market going forward. Customized medicine refers to the medical care practice that customizes healthcare decisions and actions to the particularities of every patient, taking into account aspects like genetics, environment, and way of life. Whole genome and exome sequencing aids in customized medicine by providing an all-encompassing examination of a person’s genetic structure. This allows health care decisions and actions to be customized based on their distinct genetic, environmental, and lifestyle factors. For instance, the Personalized Medicine Coalition (PMC), a US-based entity that encourages the comprehension and adoption of personalized medicine, projected in October 2022 that in excess of 75,000 genetic testing products and 300 personalized medicines will grace the market in 2022. Moreover, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave the green light to 37 new molecular entities (NMEs) in 2022. Of the 35 therapeutic NMEs, nearly 34%, amounting to 12, fall under the personalized category. As a consequence, the growing demand for personalized medicine is acting as a catalyst for the growth of the whole genome and exome sequencing market.

Get Your Free Sample of the Global Whole Genome And Exome Sequencing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Whole Genome And Exome Sequencing Market?

Major companies operating in the whole genome and exome sequencing market report are:

• Siemens AG_x000D_

• Hoffmann-La Roche Ltd._x000D_

• Thermo Fisher Scientific Inc._x000D_

• Cytiva (Danaher Corporation)_x000D_

• Laboratory Corporation of America Holdings (Labcorp)_x000D_

What Current Trends in the Whole Genome And Exome Sequencing Market Should Industry Players Pay Attention To?

Leading companies in the whole genome and exome sequencing markets are shifting their efforts to create cutting-edge technological systems, like ultra-fast NGS (next-generation sequencing) analysis, to stand out in the market. This new technology allows the processing of next-generation sequencing (NGS) data at an unprecedented pace, drastically cutting down on the time needed for genomic data analysis. To demonstrate, in January 2023, QIAGEN Digital Insights (QDI), a bioinformatics firm in the US, unveiled their ultra-fast NGS analysis platform. This platform boasts capabilities such as completing a whole genome process in 25 minutes at a cloud computing cost of $1, thus encouraging efficiency, cost-effectiveness, and scalability. This technological breakthrough significantly improves the speed and availability of genomic data analysis, making it particularly valuable in the whole genome and exome sequencing market by facilitating prompt decision-making and broader implementation of personalized medicine.

Get Instant Access to the Global Whole Genome And Exome Sequencing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Whole Genome And Exome Sequencing Market?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Which Regions Are Significant to the Growth of the Whole Genome And Exome Sequencing Market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Whole Genome And Exome Sequencing Market’s Scope?

Whole genome sequencing (WGS) and exome sequencing (ES) are comprehensive genetic analysis techniques that involve determining the complete DNA sequence of an organism’s genome and sequencing the protein-coding regions of the genome. These analyses are used to sequence a person’s DNA for diagnosing genetic diseases and identifying cancer mutations.

Browse Through More Similar Reports By The Business Research Company:

Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Prenatal DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: